多巴胺
神经递质
去甲肾上腺素
神经科学
疾病
血清素
儿茶酚胺
单胺类
平衡
生物
免疫系统
医学
内分泌学
内科学
中枢神经系统
免疫学
受体
作者
Rahul Mittal,Luca H. Debs,Amit Patel,Desiree Nguyen,Kunal Patel,Gregory O’Connor,M’hamed Grati,Jeenu Mittal,Denise Yan,Adrien A. Eshraghi,Sapna K. Deo,Sylvia Daunert,Xue Zhong Liu
摘要
Neurotransmitters, including catecholamines and serotonin, play a crucial role in maintaining homeostasis in the human body. Studies on these neurotransmitters mainly revolved around their role in the "fight or flight" response, transmitting signals across a chemical synapse and modulating blood flow throughout the body. However, recent research has demonstrated that neurotransmitters can play a significant role in the gastrointestinal (GI) physiology. Norepinephrine (NE), epinephrine (E), dopamine (DA), and serotonin have recently been a topic of interest because of their roles in the gut physiology and their potential roles in GI and central nervous system pathophysiology. These neurotransmitters are able to regulate and control not only blood flow, but also affect gut motility, nutrient absorption, GI innate immune system, and the microbiome. Furthermore, in pathological states, such as inflammatory bowel disease (IBD) and Parkinson's disease, the levels of these neurotransmitters are dysregulated, therefore causing a variety of GI symptoms. Research in this field has shown that exogenous manipulation of catecholamine serum concentrations can help in decreasing symptomology and/or disease progression. In this review article, we discuss the current state-of-the-art research and literature regarding the role of neurotransmitters in regulation of normal GI physiology, their impact on several disease processes, and novel work focused on the use of exogenous hormones and/or psychotropic medications to improve disease symptomology. J. Cell. Physiol. 232: 2359-2372, 2017. © 2016 Wiley Periodicals, Inc.
科研通智能强力驱动
Strongly Powered by AbleSci AI